The intrahippocampal kainate model of temporal lobe epilepsy revisited: Epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats

Epilepsy Research

Volumn 103, Issue 2-3, 2013, Pages 135-152

  Rattka, Marta ^a,b   Brandt, Claudia ^a,b   Löscher, Wolfgang ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Antiepileptic drugs; Hippocampus; Learning and memory; Phenobarbital; Seizures

Indexed keywords

KAINIC ACID; PHENOBARBITAL;

ANESTHESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN DAMAGE; CELLULAR DISTRIBUTION; COGNITION; CONTROLLED STUDY; DENTATE HILUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG INDUCED DISEASE; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EPILEPTOGENESIS; EXCITABILITY; FEMALE; GRANULE CELL; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; INTRAHIPPOCAMPAL DRUG ADMINISTRATION; LEARNING DISORDER; LIMBIC SYSTEM; MAZE TEST; MEMORY DISORDER; MORTALITY; NERVE CELL NECROSIS; NEUROMONITORING; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; TEMPORAL LOBE EPILEPSY; TREATMENT RESPONSE; WAKEFULNESS;

ANIMALS; ANTICONVULSANTS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HYPERKINESIS; KAINIC ACID; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84873084581     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.09.015     Document Type: Article

References (78)

1. Arabadzisz D., Antal K., Parpan F., Emri Z., Fritschy J.M. Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus. Exp. Neurol. 2005, 194:76-90.
2. Babb T.L., Pereira-Leite J., Mathern G.W., Pretorius J.K. Kainic acid induced hippocampal seizures in rats: comparisons of acute and chronic seizures using intrahippocampal versus systemic injections. Ital. J. Neurol. Sci. 1995, 16:39-44.
3. Balish M., Albert P.S., Theodore W.H. Seizure frequency in intractable partial epilepsy: a statistical analysis. Epilepsia 1991, 32:642-649.
4. Bankstahl J.P., Hoffmann K., Bethmann K., Löscher W. Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain. Neuropharmacology 2008, 54:1006-1016.
5. Bauer J., Burr W. Course of chronic focal epilepsy resistant to anticonvulsant treatment. Seizure 2001, 10:239-246.
6. Baulac M. Phenobarbital and other barbiturates: clinical efficacy and use in epilepsy. Antiepileptic Drugs 2002, 514-521. Lippincott Williams & Wilkins, Philadelphia. 5th ed. R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca (Eds.).
7. Ben Ari Y., Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 2000, 23:580-587.
8. Ben Ari Y., Tremblay E., Ottersen O.P., Naquet R. Evidence suggesting secondary epileptogenic lesion after kainic acid: pre treatment with diazepam reduces distant but not local brain damage. Brain Res. 1979, 165:362-365.
9. Ben-Ari Y. Limbic seizures and brain damage produced by kainic acid: mechanisms and relevance in human temporal lobe epilepsy. Neuroscience 1985, 14:375-403.
10. Bertram E.H. Temporal lobe epilepsy: where do the seizures really begin?. Epilepsy Behav. 2009, 14(Suppl. 1):32-37.
11. Bethmann K., Brandt C., Löscher W. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Epilepsia 2007, 48:816-826.
12. Bolding K., Rudy J.W. Place learning in the Morris water task: making the memory stick. Learn. Mem. 2006, 13:278-286.
13. Bouilleret V., Ridoux V., Depaulis A., Marescaux C., Nehlig A., Lasalle G.L. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 1999, 89:717-729.
14. Bragin A., Engel J., Wilson C.L., Vizentin E., Mathern G.W. Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection. Epilepsia 1999, 40:1210-1221.
15. Bragin A., Wilson C.L., Almajano J., Mody I., Engel J. High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 2004, 45:1017-1023.
16. Bragin A., Azizyan A., Almajano J., Wilson C.L., Engel J. Analysis of chronic seizure onsets after intrahippocampal kainic acid injection in freely moving rats. Epilepsia 2005, 46:1592-1598.
17. Bragin A., Azizyan A., Almajano J., Engel J. The cause of the imbalance in the neuronal network leading to seizure activity can be predicted by the electrographic pattern of the seizure onset. J. Neurosci. 2009, 29:3660-3671.
18. Brandt C., Glien M., Potschka H., Volk H., Löscher W. Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats. Epilepsy Res. 2003, 55:83-103.
19. Brandt C., Volk H.A., Löscher W. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Epilepsia 2004, 45:1488-1497.
20. Brandt C., Gastens A.M., Sun M.Z., Hausknecht M., Löscher W. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 2006, 51:789-804.
21. Brandt C., Glien M., Gastens A.M., Fedrowitz M., Bethmann K., Volk H.A., Potschka H., Löscher W. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 2007, 53:207-221.
22. Brandt C., Nozadze M., Heuchert N., Rattka M., Löscher W. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. J. Neurosci. 2010, 30:8602-8612.
23. Cascino G.D. Temporal lobe epilepsy: more than hippocampal pathology. Epilepsy Curr. 2005, 5:187-189.
24. Cavalheiro E.A., Riche D.A., Le Gal L.S. Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroencephalogr. Clin. Neurophysiol. 1982, 53:581-589.
25. Cavalheiro E.A., Naffah-Mazacoratti M.G., Mello L.E., Leite J.P. The pilocarpine model of seizures. Models of Seizures and Epilepsy 2006, 433-448. Elsevier, Amsterdam. A. Pitkänen, P.A. Schwartzkroin, S.L. Moshé (Eds.).
26. Chang B.S., Lowenstein D.H. Epilepsy. N. Engl. J. Med. 2003, 349:1257-1266.
27. Curia G., Longo D., Biagini G., Jones R.S., Avoli M. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods 2008, 172:143-157.
28. Davenport C.J., Brown W.J., Babb T.L. GABAergic neurons are spared after intrahippocampal kainate in the rat. Epilepsy Res. 1990, 5:28-42.
29. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res. Brain Res. Rev. 2001, 36:60-90.
30. Dichter M.A. Emerging concepts in the pathogenesis of epilepsy and epileptogenesis. Arch. Neurol. 2009, 66:443-447.
31. Dudek F.E., Staley K.J. The time course of acquired epilepsy: implications for therapeutic intervention to suppress epileptogenesis. Neurosci. Lett. 2011, 497:240-246.
32. Dudek F.E., Clark S., Williams P.A., Grabenstatter H.L. Kainate-induced status epilepticus: a chronic model of acquired epilepsy. Models of Seizures and Epilepsy 2006, 415-432. Elsevier, Amsterdam. A. Pitkänen, P.A. Schwartzkroin, S.L. Moshé (Eds.).
33. Fujikawa D.G., Itabashi H.H., Wu A., Shinmei S.S. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 2000, 41:981-991.
34. Furtado M.A., Castro O.W., Del Vecchio F., de Oliveira J.A., Garcia-Cairasco N. Study of spontaneous recurrent seizures and morphological alterations after status epilepticus induced by intrahippocampal injection of pilocarpine. Epilepsy Behav. 2011, 20:257-266.
35. Gernert M., Löscher W. Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats. Eur. J. Pharmacol. 2001, 432:35-41.
36. Glien M., Brandt C., Potschka H., Löscher W. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 2002, 43:350-357.
37. Goffin K., Nissinen J., Van Laere K., Pitkänen A. Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat. Exp. Neurol. 2007, 205:501-505.
38. Goodman J.H. Experimental models of status epilepticus. Neuropharmacology Methods in Epilepsy Research 1998, 95-125. CRC Press, Boca Raton. S.L. Peterson, T.E. Albertson (Eds.).
39. Gouder N., Fritschy J.M., Boison D. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 2003, 44:877-885.
40. Gröticke I., Hoffmann K., Löscher W. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate. Exp. Neurol. 2008, 213:71-83.
41. Handelmann G.E., Olton D.S. Spatial memory following damage to hippocampal CA3 pyramidal cells with kainic acid: impairment and recovery with preoperative training. Brain Res. 1981, 217:41-58.
42. Haut S.R. Seizure clustering. Epilepsy Behav. 2006, 8:50-55.
43. Haut S.R., Swick C., Freeman K., Spencer S. Seizure clustering during epilepsy monitoring. Epilepsia 2002, 43:711-715.
44. Jarrard L.E. Use of excitotoxins to lesion the hippocampus: update. Hippocampus 2002, 12:405-414.
45. Kücker S., Töllner K., Piechotta M., Gernert M. Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity. Neurobiol. Dis. 2010, 37:661-672.
46. Langer M., Brandt C., Löscher W. Marked strain and substrain differences in induction of status epilepticus and subsequent development of neurodegeneration, epilepsy, and behavioral alterations in rats. Epilepsy Res. 2011, 96:207-224.
47. Leite J.P., Babb T.L., Pretorius J.K., Kuhlman P.A., Yeoman K.M., Mathern G.W. Neuron loss, mossy fiber sprouting, and interictal spikes after intrahippocampal kainate in developing rats. Epilepsy Res. 1996, 26:219-231.
48. Leite J.P., Garcia-Cairasco N., Cavalheiro E.A. New insights from the use of pilocarpine and kainate models. Epilepsy Res. 2002, 50:93-103.
49. Löscher W. Animal models of epilepsy and epileptic seizures. Antiepileptic Drugs. Handbook of Experimental Pharmacology 1999, 19-62. Springer, Berlin. M.J. Eadie, F. Vajda (Eds.).
50. Löscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 2011, 20:359-368.
51. Löscher W., Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol. Rev. 2010, 62:668-700.
52. Löscher W., Köhling R. Functional, metabolic, and synaptic changes after seizures as potential targets for antiepileptic therapy. Epilepsy Behav. 2010, 19:105-113.
53. Maroso M., Balosso S., Ravizza T., Iori V., Wright C.I., French J., Vezzani A. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011, 8:304-315.
54. Mascott C.R., Gotman J., Beaudet A. Automated EEG monitoring in defining a chronic epilepsy model. Epilepsia 1994, 35:895-902.
55. Mazarati A.M., Thompson K.W., Suchomelova L., Sankar R., Shirasaka Y., Nissinen J., Pitkänen A., Bertram E., Wasterlain C. Status epilepticus: electrical stimulation models. Models of Seizures and Epilepsy 2006, 449-464. Elsevier, Amsterdam. M. Pitkänen, P.A. Schwartzkroin, S.L. Moshé (Eds.).
56. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
57. Moser V.C., McCormick J.P., Creason J.P., MacPhail R.C. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 1988, 11:189-206.
58. Müller C.J., Gröticke I., Bankstahl M., Löscher W. Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL/6 mice. Exp. Neurol. 2009, 219:284-297.
59. Munoz C., Grossman S.P. Some behavioral effects of selective neuronal depletion by kainic acid in the dorsal hippocampus of rats. Physiol. Behav. 1980, 25:581-587.
60. Nissinen J., Pitkänen A. Effect of antiepileptic drugs on spontaneous seizures in epileptic rats. Epilepsy Res. 2007, 73:181-191.
61. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Elsevier, Amsterdam. 6th ed.
62. Polascheck N., Bankstahl M., Löscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp. Neurol. 2010, 224:219-233.
63. Potschka H., Fedrowitz M., Löscher W. P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci. Lett. 2002, 327:173-176.
64. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
65. Raedt R., Van Dycke A., Van Melkebeke D., De Smedt T., Claeys P., Wyckhuys T., Vonck K., Wadman W., Boon P. Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat. Acta Neurol. Scand. 2009, 119:293-303.
66. Raedt R., Van Dycke A., Waeytens A., Wyckhuys T., Vonck K., Wadman W., Boon P. Unconditioned adult-derived neurosphere cells mainly differentiate towards astrocytes upon transplantation in sclerotic rat hippocampus. Epilepsy Res. 2009, 87:148-159.
67. Rattka M., Brandt C., Bankstahl M., Bröer S., Löscher W. Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats. Neuropharmacology 2011, 60:505-512.
68. Rattka M., Brandt C., Löscher W. Do proconvulsants modify or halt epileptogenesis? Pentylenetetrazole is ineffective in two rat models of temporal lobe epilepsy. Eur. J. Neurosci. 2012, 36:2505-2520.
69. Riban V., Bouilleret V., Pham L., Fritschy J.M., Marescaux C., Depaulis A. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 2002, 112:101-111.
70. Rice A.C., Floyd C.L., Lyeth B.G., Hamm R.J., DeLorenzo R.J. Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. Epilepsia 1998, 39:1148-1157.
71. Roucard C., Bressand K., Depaulis A. Resistance to classical antiepileptic drugs in the MTLE mouse: a model of Mesial Temporal Lobe Epilepsy to explore new mechanisms of actions?. American Epilepsy Society, Annual Meeting, Abstract No. 2.387 2010, http://www.aesnet.org/.
72. Schwarcz R., Zaczek R., Coyle J.T. Microinjection of kainic acid into the rat hippocampus. Eur. J. Pharmacol. 1978, 50:209-220.
73. Sloviter R.S. Hippocampal pathology and pathophysiology in temporal lobe epilepsy. Neurologia 1996, 11(Suppl. 4):29-32.
74. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 1994, 42:1-32.
75. Tanaka S., Kondo S., Tanaka T., Yonemasu Y. Long-term observation of rats after unilateral intra-amygdaloid injection of kainic acid. Brain Res. 1988, 463:163-167.
76. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., Cavalheiro E.A. Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel model of intractable epilepsy. Synapse 1989, 3:154-171.
77. Wieser H.G. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004, 45:695-714.
78. Wlaz P., Ebert U., Löscher W. Microinjection of kainic acid into the amygdala of the rat as a model of limbic epilepsy with recurrent spontaneous seizures. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362(Suppl.):R49.